Cite
HARVARD Citation
Rummel, M. et al. (2021). A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study). British journal of haematology. pp. 1123-1133. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rummel, M. et al. (2021). A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study). British journal of haematology. pp. 1123-1133. [Online].